Lymphocytes & Sarcoidosis Inflammation


Trial Objective

Lymphocytes & Sarcoidosis InflammationResearchers want to learn how lymphocytes control inflammation in sarcoidosis patients, and if lymphocytes are the reason why each patient experiences a different outcome of the disease. The goal is to better understand lymphocytes to be able to identify different states of the disease and to identify new treatment options.


Active Clinical Trials Currently Recruiting

Who Can Participate

Nonsmoking adults who have sarcoidosis, diagnosed through biopsy in the last 18 months, and who are not on immunosuppressive therapy.

Age: 18+    Gender: Any Gender

Estimated Time Commitment

Not Specified

Payment & Reimbursement  

Payment: Provided

Travel Reimbursement: Not Available

Trial Contact

For more information, contact:

Christine Riley

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors

National Institutes of Health

Principal Investigators

Request More Information

By completing this form, you agree to learn more about this study and see if you qualify.

 I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health: